LEISHMANIASIS--ALLOPURINOL TREATMENT

利什曼病——别嘌呤醇治疗

• 批准号: 6234672
• 负责人: JAMES H MAGUIRE
• 金额: $ 7.76万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-07-01 至 1998-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6234672
• 关键词: Brazil; Leishmania; allopurinol; antimony; antiprotozoal agents; clinical trials; combination chemotherapy; drug adverse effect; drug screening /evaluation; human subject; human therapy evaluation; injection /infusion; leishmaniasis; microorganism disease chemotherapy; oral administration; relapse /recurrence; tropical medicine; Brazil; Leishmania; allopurinol; antimony; antiprotozoal agents; clinical trials; combination chemotherapy; drug adverse effect; drug screening /evaluation; human subject; human therapy evaluation; injection /infusion; leishmaniasis; microorganism disease chemotherapy; oral administration; relapse /recurrence; tropical medicine

暂无数据